OR WAIT null SECS
March 02, 2024
Swissmedic issues updated guidance relating to APIs, temporary authorization, and fast-track authorizations.
February 02, 2024
The UK’s IRP increases flexibility and will help speed up product approvals and patient access to medicines.
January 02, 2024
The EHDS aims to increase access to health data, but how will it impact pharma?
December 02, 2023
What does the 2024 VPAS mean for pharma?
November 02, 2023
The EU’s AI Act is set to become the world’s first comprehensive legal framework for artificial intelligence.
September 28, 2023
The new framework will position the UK as an attractive prospect for new medicine manufacturers.
September 02, 2023
The ACT EU initiative aims to develop the European Union further as a competitive centre for innovative clinical research.
August 02, 2023
What impact will EMA’s decision to phase out COVID-19 regulatory flexibilities have on the pharma industry?
July 02, 2023
Changes to PRIME scheme are set to drive greater harmonization across major pharmaceutical markets.
June 02, 2023
What implications will EMA’s recent regulatory reform have on pharma?